Finance

Lists
1786:TPE
SciVision Biotech Inc
NT$49,95
-1,28%
(-0,65) 1D
16 Nov., 13:30:34 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1786...
Open
NT$50,50
High
NT$53,30
Low
NT$49,95
Mkt. cap
3,74 mjd
Avg. vol.
730,08 k
Volume
812,20 k
Dividend
3,82%
Quarterly dividend
NT$0,48
Ex-dividend date
24 Jul. 2024
P/E ratio
27,34
52-wk high
NT$87,50
52-wk low
NT$38,80
EPS
NT$1,83
Shares outstanding
53,10 m
No. of employees
64
Open
NT$50,50
High
NT$53,30
Low
NT$49,95
Mkt. cap
3,74 mjd
Avg. vol.
730,08 k
Volume
812,20 k
Dividend
3,82%
Quarterly dividend
NT$0,48
Ex-dividend date
24 Jul. 2024
P/E ratio
27,34
52-wk high
NT$87,50
52-wk low
NT$38,80
EPS
NT$1,83
Shares outstanding
53,10 m
No. of employees
64
News stories
From web sources and news partners
About SciVision Biotech Inc
CEO-
Employees64
Founded1990
Headquarters-
SectorHealth Care
IndustryMedical device
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
251,39 m
205,32 m
211,03 m
202,67 m
Cost of goods sold
62,04 m
60,12 m
71,98 m
61,50 m
Cost of revenue
62,04 m
60,12 m
71,98 m
61,50 m
Research and development expenses
32,38 m
22,94 m
20,75 m
22,83 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
107,04 m
100,96 m
89,57 m
85,47 m
Operating expense
139,42 m
123,90 m
110,32 m
108,30 m
Total operating expenses
201,46 m
184,02 m
182,30 m
169,80 m
Operating income
49,93 m
21,30 m
28,73 m
32,87 m
Other non operating income
2,19 m
1,30 m
51,00 k
-9,91 m
EBT including unusual items
72,40 m
35,68 m
27,57 m
24,25 m
EBT excluding unusual items
74,54 m
35,70 m
28,60 m
24,25 m
Income tax expense
9,21 m
13,73 m
-7,08 m
1,22 m
Effective tax rate
12,72%
38,47%
-25,67%
5,02%
Other operating expenses
-
-
-
-
Net income
63,18 m
21,96 m
34,64 m
23,03 m
Net profit margin
25,13%
10,69%
16,42%
11,37%
Earnings per share
-
-
-
-
Interest and investment income
8,75 m
6,50 m
7,42 m
4,43 m
Interest expense
-3,18 m
-3,12 m
-3,10 m
-3,14 m
Net interest expenses
5,57 m
3,37 m
4,32 m
1,29 m
Depreciation and amortization charges
-
-
-
-
EBITDA
68,84 m
41,06 m
49,04 m
61,78 m
Gain or loss from assets sale
10,00 k
16,00 k
-23,00 k
-
Upcoming events
AI content may include mistakes. Learn more
Google-programme